Assessing Cannabis Use in People with Psychosis
Abstract Introduction: Cannabis use is common in people with psychotic disorders and is associated with the exacerbation of symptoms, poor…
Abstract Introduction: Cannabis use is common in people with psychotic disorders and is associated with the exacerbation of symptoms, poor…
Abstract Introduction: Cannabidiol (CBD) has been shown to maintain bone integrity in pre-clinical models, but little is known about the…
Abstract Background: With the legalization of cannabis in Canada, consumers are presented with numerous purchase options. Licensed retailers are limited…
Abstract Benzodiazepines (BZDs) such as oxazepam are commonly prescribed depressant drugs known for their anxiolytic, hypnotic, muscle relaxant, and anticonvulsant…
Abstract Background: As of November 2023, twenty-four states, two territories, and DC have legalized marijuana for non-medical use, leading to…
Abstract Background: There is ongoing uncertainty about whether cannabis use increases the risk of developing an anxiety disorder. In this…
Abstract Delta 9 tetrahydrocannabinol (THC), the main component of cannabis, has adverse effects on the cardiovascular system, but whether concomitant…
Abstract This study aims to analyze changes in health-related quality of life (HRQoL) and safety in patients with generalized anxiety…
Abstract This study aimed to design a THC-rich hydrogel to deliver cannabis derivatives topically. We developed hydrogels using polyvinyl alcohol…
Abstract Background: Back pain is the leading cause of disability worldwide. Despite guidelines discouraging opioids as first-line treatment, opioids remain…